||EPS - Basic
||Market Cap (m)
|Pharmaceuticals & Biotechnology
Sareum Share Discussion Threads
Showing 27551 to 27574 of 27575 messages
|to whoever goes to the conference tomorrow,
maybe worth questioning them about the SKIL platform, have we ever in the past been approached to sell this , and whether its ever been considered to be sold off?|
|thanks skez and nobby be great to hear any titbits from conference...!|
|Note the increase in operating expenses-at £750k a record high for a six month period and compare wit the year before comparative of £449k which was typical of 6 month opex in the 2013/4/5 period.
I assume opex in calender 2017 will be higher as they put the foot on the gas with TYK research|
|There is an interview with Tim on Proactive Investor. It seems like they are close to licensing another program. Presumably this is why they will only make a 'modest' profit for the full year because this will take some of the cash!
|Don't forget the presentation at the Biotech conference tomorrow. Timbo and myself at least will be there. We may get to learn the odd gem during a post seminar discussion....
|yup bob that could land any time this year, along with interest in tyk2 and progress on Aurora .. 3 potential multi bagging events|
|The anchor that keeps me here & tempts me to top up, is the milestone could be triggered at any point, if Sierra Oncology make a breakthrough giving us access to some or all of the $319 million! We are remote from their activities, so it could come out of the blue.|
that is in regard to chk1
we still have potential news on other fronts Aurora and TYK2 to keep things going.|
|Just a reminder....Additional payments in the aggregate amount of up to US$319.5 million may become payable upon achievement of certain development, regulatory and commercial milestones.|
|well if not further payments expected until after year end per RNS (DYOR) then IMO it just may drift until people anticipate the next potentially big RNS which could be c.6 months away....DYOR and all IMO...like the story, but not sure share price is heading too far in the short-term
|The RNS today is featured in the Penny Stock Post, nice readable version of events.
|lets see if the instituitions ramp up their buying today|
|maiden profit too.. slowly but surely|
|Modest profit is good. If they then exceed expectations the even better. Should see a decent sustained slow gradual rise from 1.1p over the next few months|
|Did say we won't expect anything new. They will just tell us what we already know. However they will still make a modest profit.|
|The big hope has no more milestones in the foreseeable future and the other programmes are very early stage and will need funding, hence market cap is too high IMO. Don't hold and not short but eyes wide open.|
|£31m market cap!|
|Results as expected, may get a small tick up this morning, but I'm sitting tight and awaiting the big numbers towards the end of this year. Maybe be opportunities to buy when news gets thin on the ground and we fall back for awhile.|
|P&F chart suggests price objective 2.38p next stop (not when though :( )
|No its a graph. Bobby I've held Sar for nearly 10 years. First bought at 1.2p only to see it sink to 0.006p but held and was handsomely regarded back in February 2011 when they shot up to 5.5p from 0.5p in few days. But now the game has changed. Sar is producing revenue so 10p plus on cards|
|Spacedust ...... do you mean chart? WOBH|
|Too long spacedust, too long. However, I think we're about to be handsomely rewarded.|
|Graph says 1.4p next stop and possibly 1.6p|